• LAST PRICE
    9.0200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    8.9300/ 2
  • Ask / Lots
    9.4700/ 2
  • Open / Previous Close
    9.0300 / 9.0200
  • Day Range
    Low 8.9100
    High 9.1350
  • 52 Week Range
    Low 4.2600
    High 16.9000
  • Volume
    446,615
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 9.02
TimeVolumeATXS
09:32 ET69099.03
09:34 ET36368.98
09:36 ET3008.95
09:38 ET2009
09:39 ET11009.105
09:43 ET3239.06
09:45 ET1009.09
09:48 ET3009.11
09:52 ET2009.09
09:56 ET1009.06
09:57 ET1009.07
09:59 ET3009.065
10:01 ET6509.072
10:03 ET56299.005
10:06 ET6009.035
10:08 ET3239.02
10:10 ET1409.025
10:12 ET1009.045
10:14 ET1009.06
10:15 ET1009.055
10:17 ET2989.07
10:19 ET5009.068
10:26 ET2009.055
10:33 ET3719.045
10:35 ET6929.02
10:37 ET9269.06
10:42 ET2439.07
10:44 ET12009.055
10:50 ET2009.055
10:51 ET18049.035
10:55 ET1009.02
10:57 ET3009.04
11:02 ET2009.04
11:06 ET83709
11:08 ET6009.02
11:09 ET7009.05
11:11 ET2009.085
11:15 ET1009.09
11:18 ET6009.08
11:22 ET2009.0802
11:24 ET1009.09
11:26 ET4009.105
11:33 ET4009.12
11:36 ET10439.12
11:40 ET5449.08
11:44 ET10939.06
11:47 ET2539.05
11:49 ET1009.06
11:51 ET4089.035
11:54 ET6909.03
11:56 ET2089.02
11:58 ET2009.005
12:03 ET3009
12:05 ET17659.005
12:07 ET28069.035
12:09 ET9129.04
12:12 ET9939.02
12:16 ET11029.04
12:18 ET6009.04
12:20 ET3509.04
12:21 ET1009.05
12:23 ET1009.04
12:25 ET8509.065
12:27 ET4379.06
12:32 ET3009.06
12:34 ET9009.02
12:38 ET11489
12:48 ET19219.03
12:50 ET8059.04
12:52 ET1009.035
12:54 ET16099.02
12:56 ET1009.02
12:59 ET5269.01
01:01 ET2009
01:03 ET2009.02
01:06 ET24209.01
01:08 ET5499.02
01:14 ET9009.03
01:15 ET6009.035
01:21 ET17479.03
01:24 ET1009.03
01:30 ET6029
01:32 ET2009
01:33 ET15409.005
01:35 ET3009.005
01:37 ET213218.98
01:39 ET4378.96
01:42 ET83088.98
01:44 ET16599.03
01:46 ET11029.06
01:48 ET5009.05
01:50 ET11009.035
01:51 ET19049.02
01:53 ET1009.02
02:00 ET29029
02:02 ET3009
02:04 ET19439
02:06 ET6008.99
02:08 ET1508.998
02:11 ET1008.99
02:13 ET12078.99
02:15 ET13008.995
02:18 ET3009
02:20 ET6199.04
02:22 ET16249
02:26 ET14119.005
02:27 ET15009
02:29 ET2009
02:31 ET8009
02:36 ET19509
02:38 ET6009
02:40 ET15509.01
02:42 ET3009
02:44 ET3009
02:45 ET18369.005
02:47 ET11119.005
02:49 ET1009
02:51 ET18768.995
02:54 ET5008.995
02:56 ET17858.995
02:58 ET3008.995
03:00 ET2008.995
03:02 ET46479.015
03:03 ET12939
03:05 ET6599.015
03:07 ET3009.03
03:12 ET1009.03
03:14 ET5009.02
03:16 ET15009.01
03:18 ET4009.015
03:20 ET13039.03
03:21 ET2009.025
03:23 ET2009.025
03:25 ET9659.015
03:27 ET1009.01
03:30 ET2009.01
03:32 ET21149.03
03:34 ET3009.035
03:36 ET4899.03
03:38 ET1009.035
03:39 ET46099.055
03:41 ET29289.065
03:43 ET20739.05
03:45 ET58079.0275
03:48 ET10009.03
03:50 ET1009.035
03:52 ET90059.005
03:54 ET338228.94
03:56 ET605948.98
03:57 ET123109.015
03:59 ET148709.02
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesATXS
Astria Therapeutics Inc
495.3M
-3.9x
---
United StatesAVTE
Aerovate Therapeutics Inc
492.3M
-5.6x
---
United StatesCELC
Celcuity Inc
488.4M
-5.6x
---
United StatesOLMA
Olema Pharmaceuticals Inc
506.8M
-4.5x
---
United StatesLXEO
Lexeo Therapeutics Inc
509.3M
-5.7x
---
United StatesCRBP
Corbus Pharmaceuticals Holdings Inc
481.1M
-6.5x
---
As of 2024-05-27

Company Information

Astria Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for allergic and immunological diseases. The Company's lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development for the treatment of hereditary angioedema (HAE), a rare, debilitating and potentially life-threatening disease. Its second program, STAR-0310, is a monoclonal antibody OX40 antagonist in preclinical development for the treatment of atopic dermatitis (AD). The Company owns two patent families directed to STAR-0215. The first patent family is directed to the composition of matter of its product candidate STAR-0215 and its use in treating various plasma kallikrein associated disorders including HAE. In the second patent family, the Company owns one International (PCT) patent application directed to methods of treating various plasma-kallikrein associated disorders, including HAE, with specific dosing regimens of the STAR-0215 antibody.

Contact Information

Headquarters
75 State Street, Suite 1400BOSTON, MA, United States 02109
Phone
617-349-1971
Fax
617-273-2637

Executives

Independent Chairman of the Board
Kenneth Bate
President, Chief Executive Officer, Co-Founder, Director
Jill Milne
Chief Financial Officer
Noah Clauser
Chief Legal Officer
Benjamin Harshbarger
Chief Commercial Officer
Andrew Komjathy

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$495.3M
Revenue (TTM)
$0.00
Shares Outstanding
54.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.77
EPS
$-2.32
Book Value
$5.92
P/E Ratio
-3.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.